Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
Lihong Liu, Sho Iketani, Yicheng Guo, et al.
Nature (2021)
Closed Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2
Andrea L. Cathcart, Colin Havenar‐Daughton, Florian A. Lempp, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 241
Increased immune escape of the new SARS-CoV-2 variant of concern Omicron
Jie Hu, Pai Peng, Xiaoxia Cao, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 2, pp. 293-295
Open Access | Times Cited: 209
The Spread of SARS-CoV-2 Variant Omicron with a Doubling Time of 2.0–3.3 Days Can Be Explained by Immune Evasion
Frederic Grabowski, Marek Kochańczyk, Tomasz Lipniacki
Viruses (2022) Vol. 14, Iss. 2, pp. 294-294
Open Access | Times Cited: 109
Omicron, the great escape artist
Alexandra Flemming
Nature reviews. Immunology (2022) Vol. 22, Iss. 2, pp. 75-75
Open Access | Times Cited: 94
T cell epitopes in SARS-CoV-2 proteins are substantially conserved in the Omicron variant
Seong Jin Choi, Dong-Uk Kim, Ji Yun Noh, et al.
Cellular and Molecular Immunology (2022) Vol. 19, Iss. 3, pp. 447-448
Open Access | Times Cited: 94
Omicron BA.2 (B.1.1.529.2): High Potential for Becoming the Next Dominant Variant
Jiahui Chen, Guo‐Wei Wei
The Journal of Physical Chemistry Letters (2022) Vol. 13, Iss. 17, pp. 3840-3849
Open Access | Times Cited: 83
SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron
Syed Faraz Ahmed, Ahmed Abdul Quadeer, Matthew R. McKay
Viruses (2022) Vol. 14, Iss. 1, pp. 79-79
Open Access | Times Cited: 76
SARS-CoV-2 Variants Increase Kinetic Stability of Open Spike Conformations as an Evolutionary Strategy
Ziwei Yang, Yang Han, Shilei Ding, et al.
mBio (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 70
Oral antiviral treatments for COVID-19: opportunities and challenges
Laila Rahmah, Sunny O. Abarikwu, Amanuel Godana Arero, et al.
Pharmacological Reports (2022) Vol. 74, Iss. 6, pp. 1255-1278
Open Access | Times Cited: 70
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant
Hao Zhou, Michelle Møhlenberg, Jigarji Chaturji Thakor, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 67
Outbreak.info genomic reports: scalable and dynamic surveillance of SARS-CoV-2 variants and mutations
Karthik Gangavarapu, Alaa Abdel Latif, Julia L. Mullen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 66
Omicron Genetic and Clinical Peculiarities That May Overturn SARS-CoV-2 Pandemic: A Literature Review
Giorgio Tiecco, Samuele Storti, Melania Degli Antoni, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 1987-1987
Open Access | Times Cited: 55
Rapid development of an updated mRNA vaccine against the SARS-CoV-2 Omicron variant
Nana Zhang, Rongrong Zhang, Yifei Zhang, et al.
Cell Research (2022) Vol. 32, Iss. 4, pp. 401-403
Open Access | Times Cited: 55
Neutralization of SARS-CoV-2 Omicron BA.2 by Therapeutic Monoclonal Antibodies
Hao Zhou, Takuya Tada, Belinda M. Dcosta, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 54
Literature Review of Omicron: A Grim Reality Amidst COVID-19
Suraj Arora, Vishakha Grover, Priyanka Saluja, et al.
Microorganisms (2022) Vol. 10, Iss. 2, pp. 451-451
Open Access | Times Cited: 49
Virological characteristics of the novel SARS-CoV-2 Omicron variants including BA.2.12.1, BA.4 and BA.5
Izumi Kimura, Daichi Yamasoba, Tomokazu Tamura, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 47
An ultrapotent RBD-targeted biparatopic nanobody neutralizes broad SARS-CoV-2 variants
Xiaojing Chi, Xinhui Zhang, Shengnan Pan, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 45
Recent insights into SARS‐CoV‐2 omicron variant
Severino Jefferson Ribeiro da Silva, Alain Kohl, Lindomar Pena, et al.
Reviews in Medical Virology (2022) Vol. 33, Iss. 1
Open Access | Times Cited: 43
Antigenic sin of wild-type SARS-CoV-2 vaccine shapes poor cross-neutralization of BA.4/5/2.75 subvariants in BA.2 breakthrough infections
Bin Ju, Qing Fan, Miao Wang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 39
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Young‐Jun Park, Dora Pinto, Alexandra C. Walls, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 37
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants
Amin Addetia, Luca Piccoli, James Brett Case, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 30
Approaches to the Potential Therapy of COVID-19: A General Overview from the Medicinal Chemistry Perspective
J. Carlos Menéndez
Molecules (2022) Vol. 27, Iss. 3, pp. 658-658
Open Access | Times Cited: 31
A broadly neutralizing antibody protects Syrian hamsters against SARS-CoV-2 Omicron challenge
Biao Zhou, Runhong Zhou, Bingjie Tang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 31
A Highly Potent SARS-CoV-2 Blocking Lectin Protein
Recep Erdem Ahan, Alireza Hanifehnezhad, Ebru Şahin Kehribar, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 7, pp. 1253-1264
Open Access | Times Cited: 30
The SARS-CoV-2 Omicron (B.1.1.529) variant exhibits altered pathogenicity, transmissibility, and fitness in the golden Syrian hamster model
Shuofeng Yuan, Zi‐Wei Ye, Ronghui Liang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top